Suven Pharmaceuticals Ltd. has officially announced the appointment of Vivek Sharma as the new Executive Chairman, effective September 20, 2024. This transition comes as Vaidheesh Annaswamy steps down from the Board to take on the role of Vice-Chair of Suven’s Advisory Council, marking a significant
JV Ventures, an investment management firm with a focus on value-added infrastructure, today announced the launch of The Medical Centre (TMC). TMC is a holistic real estate solution that will create the best-in-class healthcare facility by bringing together convenient end-to-end medical services and integrated wellness
Eris Lifesciences Ltd., a leading Indian branded formulations company, today announced the expansion of its Sterile Injectables footprint through the acquisition of 51% equity stake in Swiss Parenterals Ltd. for a consideration of INR 637.50 crore. This deal also marks the entry of Eris into
Continues to build capacity for long-term growth; employee base crosses 12,000 Elxsians Tata Elxsi (BSE: 500408 | NSE: TATAELXSI), amongst the world’s leading providers of design led technology services, announced its first quarter results for the period ending 30th June 2023. Highlights of the Quarter Ended June
Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has received final approval from the United States Food and Drug Administration (USFDA) to market Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials (USRLD: Mycamine®). Micafungin for Injection is indicated to treat variety of fungal infections. It
Lipid abnormalities were determined basis the mentioned cut-offs recommended by LAI (Lipid Association of India): HDL (High-density lipoprotein) < 40 mg/dL for males HDL<50 mg/dL for females, LDL (Low-density lipoprotein) ≥130 mg/dL, total cholesterol ≥200 mg/dL, TG (Triglycerides) ≥150 m/dL The findings of this
